Emerging data reveals that retatrutide, a innovative medication, might represent a major step in weight management. This drug combines the effects of a GLP-1 analog and a GIP analog, seemingly offering a more outcome than available solutions. Study trials have revealed encouraging outcomes, including significant reductions in body and advancements